{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T12:45:24Z","timestamp":1785415524261,"version":"3.56.0"},"reference-count":201,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:00:00Z","timestamp":1778716800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Conselho Nacional de Desenvolvimento Cient\u00edfco e Tecnol\u00f3gico","award":["403558\/2021-2"],"award-info":[{"award-number":["403558\/2021-2"]}]},{"name":"Conselho Nacional de Desenvolvimento Cient\u00edfco e Tecnol\u00f3gico","award":["407958\/2022-3"],"award-info":[{"award-number":["407958\/2022-3"]}]},{"name":"Conselho Nacional de Desenvolvimento Cient\u00edfco e Tecnol\u00f3gico","award":["402469\/2025-9"],"award-info":[{"award-number":["402469\/2025-9"]}]},{"name":"Conselho Nacional de Desenvolvimento Cient\u00edfco e Tecnol\u00f3gico","award":["302961\/2017-8"],"award-info":[{"award-number":["302961\/2017-8"]}]},{"name":"Conselho Nacional de Desenvolvimento Cient\u00edfco e Tecnol\u00f3gico","award":["174296\/2023-1"],"award-info":[{"award-number":["174296\/2023-1"]}]},{"award":["403558\/2021-2"],"award-info":[{"award-number":["403558\/2021-2"]}],"id":[{"id":"https:\/\/ror.org\/03swz6y49","id-type":"ROR","asserted-by":"publisher"}]},{"award":["407958\/2022-3"],"award-info":[{"award-number":["407958\/2022-3"]}],"id":[{"id":"https:\/\/ror.org\/03swz6y49","id-type":"ROR","asserted-by":"publisher"}]},{"award":["402469\/2025-9"],"award-info":[{"award-number":["402469\/2025-9"]}],"id":[{"id":"https:\/\/ror.org\/03swz6y49","id-type":"ROR","asserted-by":"publisher"}]},{"award":["302961\/2017-8"],"award-info":[{"award-number":["302961\/2017-8"]}],"id":[{"id":"https:\/\/ror.org\/03swz6y49","id-type":"ROR","asserted-by":"publisher"}]},{"award":["174296\/2023-1"],"award-info":[{"award-number":["174296\/2023-1"]}],"id":[{"id":"https:\/\/ror.org\/03swz6y49","id-type":"ROR","asserted-by":"publisher"}]},{"name":"Instituto Nacional de Ci\u00eancia e Tecnologia de Vacinas","award":["408273\/2024-0"],"award-info":[{"award-number":["408273\/2024-0"]}]},{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"crossref","award":["RED-00118-23"],"award-info":[{"award-number":["RED-00118-23"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"crossref","award":["APQ-01058-21"],"award-info":[{"award-number":["APQ-01058-21"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"crossref"}]},{"award":["RED-00118-23"],"award-info":[{"award-number":["RED-00118-23"]}],"id":[{"id":"https:\/\/ror.org\/00nc55f03","id-type":"ROR","asserted-by":"publisher"}]},{"award":["APQ-01058-21"],"award-info":[{"award-number":["APQ-01058-21"]}],"id":[{"id":"https:\/\/ror.org\/00nc55f03","id-type":"ROR","asserted-by":"publisher"}]},{"name":"Coordenac\u0327\u00e3o de Aperfeic\u0327oamento de Pessoal de N\u00edvel Superior","award":["88887.999804\/2024-00"],"award-info":[{"award-number":["88887.999804\/2024-00"]}]},{"award":["88887.999804\/2024-00"],"award-info":[{"award-number":["88887.999804\/2024-00"]}],"id":[{"id":"https:\/\/ror.org\/00x0ma614","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Microorganisms"],"abstract":"<jats:p>Different protozoan parasites are the causative agents of tropical diseases, including malaria, toxoplasmosis, leishmaniasis, and Chagas disease (CD), which, altogether, affect over 300 million people throughout the world. Except for two recently approved malaria vaccines, individuals affected by or at risk of contracting any of these four diseases still experience a lack of effective treatments and vaccines. Many vaccine studies, including those that have reached clinical trials, are based on inactivated parasites, adjuvanted recombinant proteins, or viral vector vaccines. Here, we review the current advances towards the development of vaccines based on genetically modified live-attenuated parasites (GMLAP) as well as RNA formulations encoding parasite antigens. Because these are diseases caused by intracellular pathogens that depend on efficient T-cell responses for parasite control, these two new vaccine platforms have generated great expectations, since they are known to induce a robust cellular immune response. Although preclinical studies aimed at developing new malaria, toxoplasmosis, and leishmaniasis vaccines have led to significant progress that may soon result in clinical trials, advances in next-generation vaccines against CD are lagging behind. Increased collaborative efforts between research groups, governments, and the pharmaceutical industry, particularly in Africa, Asia, and Latin American countries, are urgently needed to accelerate the development of vaccines for all neglected and less-studied diseases.<\/jats:p>","DOI":"10.3390\/microorganisms14051112","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T07:50:15Z","timestamp":1778745015000},"page":"1112","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Next-Generation Vaccines Against Neglected Diseases: New Promises from Genetically Modified Live-Attenuated Parasites and RNA Vaccines"],"prefix":"10.3390","volume":"14","author":[{"given":"Marina Ferreira","family":"Batista-Zauli","sequence":"first","affiliation":[{"name":"Departamento de Bioqu\u00edmica e Imunologia, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, MG, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Eduarda Carvalho Guimar\u00e3es","family":"Brasil","sequence":"additional","affiliation":[{"name":"Departamento de Bioqu\u00edmica e Imunologia, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, MG, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Roberto","family":"de Almeida-J\u00fanior","sequence":"additional","affiliation":[{"name":"Departamento de Bioqu\u00edmica e Imunologia, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, MG, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e1rbara Germana Soares","family":"de Abreu","sequence":"additional","affiliation":[{"name":"Departamento de Bioqu\u00edmica e Imunologia, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, MG, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nailma Silva Aprigio","family":"dos Santos","sequence":"additional","affiliation":[{"name":"Departamento de Bioqu\u00edmica e Imunologia, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, MG, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2074-1204","authenticated-orcid":false,"given":"Mayra Fernanda","family":"Ricci","sequence":"additional","affiliation":[{"name":"Departamento de Bioqu\u00edmica e Imunologia, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, MG, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2588-2842","authenticated-orcid":false,"given":"Santuza Maria Ribeiro","family":"Teixeira","sequence":"additional","affiliation":[{"name":"Departamento de Bioqu\u00edmica e Imunologia, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, MG, Brazil"},{"name":"Centro de Tecnologia de Vacinas (CT Vacinas), Universidade Federal de Minas Gerais, Belo Horizonte 31310-260, MG, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,5,14]]},"reference":[{"key":"ref_1","unstructured":"World Health Organization (2026, January 05). Reported Number of People Requiring Interventions Against NTDs. Available online: https:\/\/www.who.int\/data\/gho\/data\/indicators\/indicator-details\/GHO\/reported-number-of-people-requiring-interventions-against-ntds."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJMra064142","article-title":"Control of neglected tropical diseases","volume":"357","author":"Hotez","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"World Health Organization (2025). World Malaria Report 2025: Addressing the Threat of Antimalarial Drug Resistance, World Health Organization. Available online: https:\/\/www.who.int\/publications\/i\/item\/9789240117822.","DOI":"10.30875\/9789287074560"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1093\/cid\/cir180","article-title":"Review of Cases with the Emerging Fifth Human Malaria Parasite, Plasmodium knowlesi","volume":"52","author":"Kantele","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Mariano, R.M.d.S., Gon\u00e7alves, A.A.M., de Oliveira, D.S., Ribeiro, H.S., Pereira, D.F.S., Santos, I.S., Lair, D.F., da Silva, A.V., Galdino, A.S., and Ch\u00e1vez-Fumagalli, M.A. (2023). A Review of Major Patents on Potential Malaria Vaccine Targets. Pathogens, 12.","DOI":"10.3390\/pathogens12020247"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0140-6736(13)60024-0","article-title":"Malaria","volume":"383","author":"White","year":"2014","journal-title":"Lancet"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJMoa2026330","article-title":"Seasonal Malaria Vaccination with or without Seasonal Malaria Chemoprevention","volume":"385","author":"Chandramohan","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_8","unstructured":"World Health Organization (2026, February 03). Malaria Vaccines (RTS, S and R21). Available online: https:\/\/www.who.int\/news-room\/questions-and-answers\/item\/q-a-on-rts-s-malaria-vaccine."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2500069","DOI":"10.2807\/1560-7917.ES.2025.30.34.2500069","article-title":"Systematic Review and Modelling of Toxoplasma gondii Seroprevalence in Humans, Europe, 2000 to 2021","volume":"30","author":"Friesema","year":"2025","journal-title":"Eurosurveillance"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.rvsc.2020.10.019","article-title":"Foodborne Transmission of Toxoplasma Gondii Infection in the Last Decade. An Overview","volume":"135","author":"Almeria","year":"2021","journal-title":"Res. Vet. Sci."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"12102","DOI":"10.1038\/s41598-020-69078-9","article-title":"Global, Regional, and Country Seroprevalence of Toxoplasma gondii in Pregnant Women: A Systematic Review, Modelling and Meta-Analysis","volume":"10","author":"Bigna","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_12","unstructured":"Madireddy, S., and Mangat, R. (2025). Toxoplasmosis, StatPearls."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e18749445281387","DOI":"10.2174\/0118749445281387240202094637","article-title":"A Comprehensive Review of Toxoplasmosis: Serious Threat to Human Health","volume":"17","author":"Khairullah","year":"2024","journal-title":"Open Public Health J."},{"key":"ref_14","unstructured":"Centers for Disease Control and Prevention (2026, February 26). About Toxoplasmosis, Available online: https:\/\/www.cdc.gov\/toxoplasmosis\/about\/index.html."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1550-7408.2008.00345.x","article-title":"The History of Toxoplasma gondii\u2014The First 100 Years","volume":"55","author":"Dubey","year":"2008","journal-title":"J. Eukaryot. Microbiol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/S0140-6736(04)16412-X","article-title":"Toxoplasmosis","volume":"363","author":"Montoya","year":"2004","journal-title":"Lancet"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e00049","DOI":"10.1016\/j.fawpar.2019.e00049","article-title":"Environmental Transmission of Toxoplasma gondii: Oocysts in Water, Soil and Food","volume":"15","author":"Shapiro","year":"2019","journal-title":"Food Waterborne Parasitol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1186\/s13071-020-04445-z","article-title":"The Life-Cycle of Toxoplasma gondii Reviewed Using Animations","volume":"13","author":"Attias","year":"2020","journal-title":"Parasit. Vectors"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1186\/s13071-015-0902-6","article-title":"Diagnosis of Toxoplasmosis and Typing of Toxoplasma Gondii","volume":"8","author":"Liu","year":"2015","journal-title":"Parasit. Vectors"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e00057-17","DOI":"10.1128\/CMR.00057-17","article-title":"Treatment of Toxoplasmosis: Historical Perspective, Animal Models, and Current Clinical Practice","volume":"31","author":"Dunay","year":"2018","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2325958219867315","DOI":"10.1177\/2325958219867315","article-title":"HIV-Related Cerebral Toxoplasmosis Revisited: Current Concepts and Controversies of an Old Disease","volume":"18","author":"Vidal","year":"2019","journal-title":"J. Int. Assoc. Provid. AIDS Care"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ejogrb.2020.10.003","article-title":"Toxoplasmosis in Pregnancy","volume":"255","author":"Ahmed","year":"2020","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s40268-017-0206-8","article-title":"Adverse Event Profile of Pyrimethamine-Based Therapy in Toxoplasmosis: A Systematic Review","volume":"17","author":"Goodwin","year":"2017","journal-title":"Drugs R D."},{"key":"ref_24","unstructured":"Organiza\u00e7\u00e3o Pan-Americana da Sa\u00fade OPAS\/OMS (2026, February 26). Leishmaniose. Available online: https:\/\/www.paho.org\/pt\/topicos\/leishmaniose."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e00123-25","DOI":"10.1128\/iai.00123-25","article-title":"New Insights into the Life Cycle, Host Cell Tropism, and Infection Amplification of Leishmania spp.","volume":"93","author":"Serravite","year":"2025","journal-title":"Infect. Immun."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Cosma, C., Maia, C., Khan, N., Infantino, M., and Del Riccio, M. (2024). Leishmaniasis in Humans and Animals: A One Health Approach for Surveillance, Prevention and Control in a Changing World. Trop. Med. Infect. Dis., 9, Erratum in Trop. Med. Infect. Dis.\u00a02025, 10, 74.","DOI":"10.3390\/tropicalmed10030074"},{"key":"ref_27","unstructured":"World Health Organization, Control of Neglected Tropical Diseases (NTD) (2010). Control of the Leishmaniases: Report of a Meeting of the WHO Expert Committee on the Control of Leishmaniases, Geneva, 22\u201326 March 2010, WHO. WHO Technical Report Series."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/s41572-025-00663-w","article-title":"Leishmaniasis","volume":"11","author":"Pareyn","year":"2025","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_29","unstructured":"World Health Organization (2026, January 05). Chagas Disease (Also Known as American Trypanosomiasis). Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/chagas-disease-(american-trypanosomiasis)."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Lidani, K.C.F., Andrade, F.A., Bavia, L., Damasceno, F.S., Beltrame, M.H., Messias-Reason, I.J., and Sandri, T.L. (2019). Chagas Disease: From Discovery to a Worldwide Health Problem. Front. Public Health, 7.","DOI":"10.3389\/fpubh.2019.00166"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.actatropica.2009.11.003","article-title":"Chagas Disease: A Latin American Health Problem Becoming a World Health Problem","volume":"115","author":"Schmunis","year":"2010","journal-title":"Acta Trop."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1590\/S0074-02761909000200008","article-title":"Nova tripanozomiaze humana: Estudos sobre a morfolojia e o ciclo evolutivo do Schizotrypanum cruzi n. gen., n. sp., ajente etiolojico de nova entidade morbida do homem","volume":"1","author":"Chagas","year":"1909","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1146\/annurev.mi.27.100173.002023","article-title":"Biology of Trypanosoma Cruzi","volume":"27","author":"Brener","year":"1973","journal-title":"Annu. Rev. Microbiol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/1756-3305-6-112","article-title":"Identification of Trypanosoma Cruzi Discrete Typing Units (DTUs) through the Implementation of a High-Resolution Melting (HRM) Genotyping Assay","volume":"6","author":"Higuera","year":"2013","journal-title":"Parasit. Vectors"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.meegid.2011.12.009","article-title":"The Revised Trypanosoma cruzi Subspecific Nomenclature: Rationale, Epidemiological Relevance and Research Applications","volume":"12","author":"Zingales","year":"2012","journal-title":"Infect. Genet. Evol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1017\/S0031182009005861","article-title":"A New Genotype of Trypanosoma Cruzi Associated with Bats Evidenced by Phylogenetic Analyses Using SSU rDNA, Cytochrome b and Histone H2B Genes and Genotyping Based on ITS1 rDNA","volume":"136","author":"Marcili","year":"2009","journal-title":"Parasitology"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0140-6736(17)31612-4","article-title":"Chagas disease","volume":"391","author":"Molina","year":"2018","journal-title":"Lancet"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1093\/cid\/cir956","article-title":"Oral Transmission of Chagas Disease","volume":"54","author":"Carvalho","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1017\/S1462399410001560","article-title":"The Endless Race between Trypanosoma Cruzi and Host Immunity: Lessons for and beyond Chagas Disease","volume":"12","author":"Junqueira","year":"2010","journal-title":"Expert Rev. Mol. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1056\/NEJMra1410150","article-title":"Chagas\u2019 Disease","volume":"373","author":"Bern","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e02021-21","DOI":"10.1128\/aac.02021-21","article-title":"Effectiveness of Nifurtimox in the Treatment of Chagas Disease: A Long-Term Retrospective Cohort Study in Children and Adults","volume":"66","author":"Falk","year":"2022","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/bs.apar.2018.02.001","article-title":"Climate Change and the Neglected Tropical Diseases","volume":"Volume 100","author":"Rollinson","year":"2018","journal-title":"Advances in Parasitology"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"e0119-2025","DOI":"10.1590\/0037-8682-0119-2025","article-title":"Home Invasion of Triatomines (Hemiptera: Reduviidae) in the Urban Area of Mato Grosso, Brazil","volume":"58","author":"Santos","year":"2025","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"400","DOI":"10.3201\/eid1603.090648","article-title":"Infection of Kissing Bugs with Trypanosoma Cruzi, Tucson, Arizona, USA","volume":"16","author":"Reisenman","year":"2010","journal-title":"Emerg. Infect. Dis."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Casulli, A. (2021). New Global Targets for NTDs in the WHO Roadmap 2021-2030. PLoS Negl. Trop. Dis., 15.","DOI":"10.1371\/journal.pntd.0009373"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/s41586-018-0318-5","article-title":"Challenges and Opportunities in Controlling Mosquito-Borne Infections","volume":"559","author":"Ferguson","year":"2018","journal-title":"Nature"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Ponte-Sucre, A., Gamarro, F., Dujardin, J.-C., Barrett, M.P., L\u00f3pez-V\u00e9lez, R., Garc\u00eda-Hern\u00e1ndez, R., Pountain, A.W., Mwenechanya, R., and Papadopoulou, B. (2017). Drug Resistance and Treatment Failure in Leishmaniasis: A 21st Century Challenge. PLoS Negl. Trop. Dis., 11.","DOI":"10.1371\/journal.pntd.0006052"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S0891-5520(05)70400-1","article-title":"Drug Resistance among Malaria and Other Parasites","volume":"11","author":"Barat","year":"1997","journal-title":"Infect. Dis. Clin. N. Am."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.0105-2896.2004.00174.x","article-title":"Role of the Toll\/Interleukin-1 Receptor Signaling Pathway in Host Resistance and Pathogenesis during Infection with Protozoan Parasites","volume":"201","author":"Gazzinelli","year":"2004","journal-title":"Immunol. Rev."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1128\/CMR.11.4.569","article-title":"Regulation and Function of T-Cell-Mediated Immunity during Toxoplasma gondii Infection","volume":"11","author":"Denkers","year":"1998","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1006\/expr.2000.4523","article-title":"Leishmania Sp: Comparative Study with Toxoplasma Gondii and Trypanosoma cruzi in Their Ability to Initialize IL-12 and IFN-\u03b3 Synthesis","volume":"95","author":"Oliveira","year":"2000","journal-title":"Exp. Parasitol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/nri1311","article-title":"Innate Immunity to Malaria","volume":"4","author":"Stevenson","year":"2004","journal-title":"Nat. Rev. Immunol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.exppara.2010.05.008","article-title":"Regulation of CD8+ T Cell Responses to Infection with Parasitic Protozoa","volume":"126","author":"Jordan","year":"2010","journal-title":"Exp. Parasitol."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Engwerda, C.R., Ng, S.S., and Bunn, P.T. (2014). The Regulation of CD4+ T Cell Responses during Protozoan Infections. Front. Immunol., 5.","DOI":"10.3389\/fimmu.2014.00498"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.pt.2012.07.001","article-title":"T Cell Exhaustion in Protozoan Disease","volume":"28","author":"Gigley","year":"2012","journal-title":"Trends Parasitol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"jcs255687","DOI":"10.1242\/jcs.255687","article-title":"Mixed Signals\u2014How Trypanosoma cruzi Exploits Host-Cell Communication and Signaling to Establish Infection","volume":"134","author":"Batista","year":"2021","journal-title":"J. Cell Sci."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Soares-Silva, M., Diniz, F.F., Gomes, G.N., and Bahia, D. (2016). The Mitogen-Activated Protein Kinase (MAPK) Pathway: Role in Immune Evasion by Trypanosomatids. Front. Microbiol., 7.","DOI":"10.3389\/fmicb.2016.00183"},{"key":"ref_58","first-page":"1","article-title":"The Value of Vaccination","volume":"Volume 697","author":"Bloom","year":"2011","journal-title":"Hot Topics in Infection and Immunity in Children VII"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Osman, M., Mistry, A., Keding, A., Gabe, R., Cook, E., Forrester, S., Wiggins, R., Di Marco, S., Colloca, S., and Siani, L. (2017). A Third Generation Vaccine for Human Visceral Leishmaniasis and Post Kala Azar Dermal Leishmaniasis: First-in-Human Trial of ChAd63-KH. PLoS Negl. Trop. Dis., 11.","DOI":"10.1371\/journal.pntd.0005527"},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"RTS, S Clinical Trials Partnership (2015). Efficacy and Safety of RTS, S\/AS01 Malaria Vaccine with or without a Booster Dose in Infants and Children in Africa: Final Results of a Phase 3, Individually Randomised, Controlled Trial. Lancet, 386, 31\u201345. Erratum in Lancet\u00a02015, 386, 30.","DOI":"10.1016\/S0140-6736(15)60721-8"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0140-6736(23)02511-4","article-title":"Safety and Efficacy of Malaria Vaccine Candidate R21\/Matrix-M in African Children: A Multicentre, Double-Blind, Randomised, Phase 3 Trial","volume":"403","author":"Datoo","year":"2024","journal-title":"Lancet"},{"key":"ref_62","first-page":"101059","article-title":"The Time Has Come for a Vaccine against Chagas Disease","volume":"45","author":"Teixeira","year":"2025","journal-title":"Lancet Reg. Health Am."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"15832","DOI":"10.1021\/acsami.3c18830","article-title":"Harnessing RNA Technology to Advance Therapeutic Vaccine Antigens against Chagas Disease","volume":"16","author":"Mancino","year":"2024","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Batista, M.F., N\u00e1jera, C.A., Meneghelli, I., and Bahia, D. (2020). The Parasitic Intracellular Lifestyle of Trypanosomatids: Parasitophorous Vacuole Development and Survival. Front. Cell Dev. Biol., 8.","DOI":"10.3389\/fcell.2020.00396"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1128\/iai.36.1.351-356.1982","article-title":"Trypanosoma cruzi Culture Used as Vaccine to Prevent Chronic Chagas\u2019 Disease in Mice","volume":"36","author":"Besuschio","year":"1982","journal-title":"Infect. Immun."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1007\/s00436-023-07880-w","article-title":"Apicomplexan Parasites Are Attenuated by Low-Energy Electron Irradiation in an Automated Microfluidic System and Protect against Infection with Toxoplasma gondii","volume":"122","author":"Finkensieper","year":"2023","journal-title":"Parasitol. Res."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.parint.2009.07.008","article-title":"Induction of Cellular and Humoral Responses by Autoclaved and Heat-Killed Antigen of Leishmania donovani in Experimental Visceral Leishmaniasis","volume":"58","author":"Nagill","year":"2009","journal-title":"Parasitol. Int."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Dos Santos, N.S.A., de Almeida-J\u00fanior, C.R., Ricci, M.F., Sanches, R.C.O., Fernandes, R.S., Burle-Caldas, G.d.A., de Castro, J.T., Reis-Cunha, J.L., Bartholomeu, D.C., and Meira, A.C.M. (2025). RNA and Protein Immunization with Trypanosoma cruzi Trans-Sialidase Containing SAPA Repeats Protects Mice against Infection and Promotes a Balanced Inflammatory Response. Front. Cell. Infect. Microbiol., 15, Erratum in Front. Cell. Infect. Microbiol.\u00a02025, 15, 1729034.","DOI":"10.3389\/fcimb.2025.1729034"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/s41541-023-00676-0","article-title":"ASP-2\/Trans-Sialidase Chimeric Protein Induces Robust Protective Immunity in Experimental Models of Chagas\u2019 Disease","volume":"8","author":"Castro","year":"2023","journal-title":"npj Vaccines"},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Chyb, M., Ferra, B.T., Kawka, M., Skwarecka, M., Dziadek, B., and Gatkowska, J. (2024). Immunogenicity and Protective Efficacy of Recombinant Chimeric Antigens Based on Surface Proteins of Toxoplasma gondii. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1480349"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"165658","DOI":"10.1016\/j.bbadis.2019.165658","article-title":"Chagas Disease Vaccine Design: The Search for an Efficient Trypanosoma cruzi Immune-Mediated Control","volume":"1866","author":"Bivona","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Lopes, K.F., Freire, M.L., Murta, S.M.F., and Oliveira, E. (2024). Efficacy of Vaccines Based on Chimeric or Multiepitope Antigens for Protection against Visceral Leishmaniasis: A Systematic Review. PLoS Negl. Trop. Dis., 18.","DOI":"10.1371\/journal.pntd.0012757"},{"key":"ref_73","unstructured":"(2026, March 09). ClinicalTrials.Gov. National Center for Biotechnology Information, Available online: https:\/\/clinicaltrials.gov\/."},{"key":"ref_74","unstructured":"World Health Organization (2026, March 09). WHO Review of Malaria Vaccine Clinical Development. Available online: https:\/\/www.who.int\/observatories\/global-observatory-on-health-research-and-development\/monitoring\/who-review-of-malaria-vaccine-clinical-development."},{"key":"ref_75","first-page":"348","article-title":"Evaluation of Cellular Immune Responses in Dogs Immunized with Alum-Precipitated Autoclaved Leishmania Major along with BCG and Imiquimod","volume":"16","author":"Barati","year":"2021","journal-title":"Iran. J. Parasitol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"eabn9709","DOI":"10.1126\/scitranslmed.abn9709","article-title":"A Genetically Engineered Plasmodium falciparum Parasite Vaccine Provides Protection from Controlled Human Malaria Infection","volume":"14","author":"Murphy","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"ref_77","first-page":"3461","article-title":"A Second Generation Leishmanization Vaccine with a Markerless Attenuated Leishmania major Strain Using CRISPR Gene Editing","volume":"11","author":"Zhang","year":"2020","journal-title":"Nature"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/s41573-024-01042-y","article-title":"mRNA vaccines for infectious diseases\u2014advances, challenges and opportunities","volume":"23","author":"Pardi","year":"2024","journal-title":"Nat. Rev. Drug. Discov."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.1225829","article-title":"A Programmable Dual-RNA\u2013Guided DNA Endonuclease in Adaptive Bacterial Immunity","volume":"337","author":"Jinek","year":"2012","journal-title":"Science"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1247997","DOI":"10.1126\/science.1247997","article-title":"Structures of Cas9 Endonucleases Reveal RNA-Mediated Conformational Activation","volume":"343","author":"Jinek","year":"2014","journal-title":"Science"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.ijpara.2018.02.002","article-title":"Assessment of Two CRISPR-Cas9 Genome Editing Protocols for Rapid Generation of Trypanosoma cruzi Gene Knockout Mutants","volume":"48","author":"DaRocha","year":"2018","journal-title":"Int. J. Parasitol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"e02097-14","DOI":"10.1128\/mBio.02097-14","article-title":"CRISPR-Cas9-Mediated Single-Gene and Gene Family Disruption in Trypanosoma cruzi","volume":"6","author":"Peng","year":"2014","journal-title":"mBio"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nprot.2017.131","article-title":"CRISPR-Cas9-Based Genome-Wide Screening of Toxoplasma gondii","volume":"13","author":"Sidik","year":"2018","journal-title":"Nat. Protoc."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/nbt.2925","article-title":"Genome Editing in the Human Malaria Parasite Plasmodium falciparum Using the CRISPR-Cas9 System","volume":"32","author":"Ghorbal","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Mogollon, C.M., van Pul, F.J.A., Imai, T., Ramesar, J., Chevalley-Maurel, S., de Roo, G.M., Veld, S.A.J., Kroeze, H., Franke-Fayard, B.M.D., and Janse, C.J. (2016). Rapid Generation of Marker-Free P. falciparum Fluorescent Reporter Lines Using Modified CRISPR\/Cas9 Constructs and Selection Protocol. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0168362"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/216160a0","article-title":"Protective Immunity produced by the Injection of X-irradiated Sporozoites of Plasmodium berghei","volume":"216","author":"Nussenzweig","year":"1967","journal-title":"Nature"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/00000441-197309000-00002","article-title":"Immunization of Man against Sporozite-Induced Falciparum Malaria","volume":"266","author":"Clyde","year":"1973","journal-title":"Am. J. Med. Sci."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1056\/NEJMoa0805832","article-title":"Protection against a Malaria Challenge by Sporozoite Inoculation","volume":"361","author":"Roestenberg","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0065-2776(08)60695-1","article-title":"Rationale for the Development of an Engineered Sporozoite Malaria Vaccine","volume":"45","author":"Nussenzweig","year":"1989","journal-title":"Adv. Immunol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"14017","DOI":"10.1073\/pnas.0805452105","article-title":"Memory CD8 T Cell Responses Exceeding a Large but Definable Threshold Provide Long-Term Immunity to Malaria","volume":"105","author":"Schmidt","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Dups, J.N., Pepper, M., and Cockburn, I.A. (2014). Antibody and B Cell Responses to Plasmodium Sporozoites. Front. Microbiol., 5.","DOI":"10.3389\/fmicb.2014.00625"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"4975","DOI":"10.1016\/j.vaccine.2013.08.007","article-title":"First-in-Human Evaluation of Genetically Attenuated Plasmodium falciparum Sporozoites Administered by Bite of Anopheles Mosquitoes to Adult Volunteers","volume":"31","author":"Spring","year":"2013","journal-title":"Vaccine"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"e00088-18","DOI":"10.1128\/IAI.00088-18","article-title":"A Plasmodium Parasite with Complete Late Liver Stage Arrest Protects against Preerythrocytic and Erythrocytic Stage Infection in Mice","volume":"86","author":"Vaughan","year":"2018","journal-title":"Infect. Immun."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/nature03188","article-title":"Genetically modified Plasmodium parasites as a protective experimental malaria vaccine","volume":"433","author":"Mueller","year":"2005","journal-title":"Nature"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"106056","DOI":"10.1016\/j.isci.2023.106056","article-title":"Plasmodium Sporozoites Require the Protein B9 to Invade Hepatocytes","volume":"26","author":"Fernandes","year":"2023","journal-title":"iScience"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"e03582","DOI":"10.7554\/eLife.03582","article-title":"A Genetically Attenuated Malaria Vaccine Candidate Based on P. falciparum B9\/Slarp Gene-Deficient Sporozoites","volume":"3","author":"Ploemen","year":"2014","journal-title":"eLife"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"eaaz5629","DOI":"10.1126\/scitranslmed.aaz5629","article-title":"A Double-Blind, Placebo-Controlled Phase 1\/2a Trial of the Genetically Attenuated Malaria Vaccine PfSPZ-GA1","volume":"12","author":"Roestenberg","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Arredondo, S.A., Swearingen, K.E., Martinson, T., Steel, R., Dankwa, D.A., Harupa, A., Camargo, N., Betz, W., Vigdorovich, V., and Oliver, B.G. (2018). The Micronemal Plasmodium Proteins P36 and P52 Act in Concert to Establish the Replication-Permissive Compartment Within Infected Hepatocytes. Front. Cell. Infect. Microbiol., 8.","DOI":"10.3389\/fcimb.2018.00413"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"eaad9099","DOI":"10.1126\/scitranslmed.aad9099","article-title":"Complete Attenuation of Genetically Engineered Plasmodium falciparum Sporozoites in Human Subjects","volume":"9","author":"Kublin","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1021\/acsinfecdis.4c00362","article-title":"A Micronemal Protein, Scot1, Is Essential for Apicoplast Biogenesis and Liver Stage Development in Plasmodium berghei","volume":"10","author":"Ghosh","year":"2024","journal-title":"ACS Infect. Dis."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/s41541-024-00975-0","article-title":"A Plasmodium late liver stage arresting GAP provides superior protection in mice","volume":"9","author":"Mishra","year":"2024","journal-title":"npj Vaccines"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1128\/IAI.01417-15","article-title":"A Plasmodium Yoelii Mei2-Like RNA Binding Protein Is Essential for Completion of Liver Stage Schizogony","volume":"84","author":"Dankwa","year":"2016","journal-title":"Infect. Immun."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/mmi.12083","article-title":"Liver-Specific Protein 2: A Plasmodium Protein Exported to the Hepatocyte Cytoplasm and Required for Merozoite Formation","volume":"87","author":"Orito","year":"2013","journal-title":"Mol. Microbiol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/s44321-024-00057-7","article-title":"A Replication Competent Plasmodium falciparum Parasite Completely Attenuated by Dual Gene Deletion","volume":"16","author":"Goswami","year":"2024","journal-title":"EMBO Mol. Med."},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Webster, R., Sekuloski, S., Odedra, A., Woolley, S., Jennings, H., Amante, F., Trenholme, K.R., Healer, J., Cowman, A.F., and Eriksson, E.M. (2021). Safety, Infectivity and Immunogenicity of a Genetically Attenuated Blood-Stage Malaria Vaccine. BMC Med., 19.","DOI":"10.1186\/s12916-021-02150-x"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.copbio.2012.04.003","article-title":"Genetic Engineering of Attenuated Malaria Parasites for Vaccination","volume":"23","author":"Khan","year":"2012","journal-title":"Curr. Opin. Biotechnol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/B978-0-12-407826-0.00003-5","article-title":"Natural Acquisition of Immunity to Plasmodium vivax: Epidemiological Observations and Potential Targets","volume":"81","author":"Mueller","year":"2013","journal-title":"Adv. Parasitol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vetpar.2009.02.026","article-title":"Toxoplasmosis in Sheep\u2014the Last 20 Years","volume":"163","author":"Dubey","year":"2009","journal-title":"Vet. Parasitol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1080\/00480169.1988.35489","article-title":"Toxoplasmosis in Sheep III. Further Evaluation of the Ability of a Live Toxoplasma Gondii Vaccine to Prevent Lamb Losses and Reduce Congenital Infection Following Experimental Oral Challenge","volume":"36","author":"Wilkins","year":"1988","journal-title":"N. Z. Vet. J."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41541-022-00563-0","article-title":"Toxoplasmosis vaccines: What we have and where to go?","volume":"7","author":"Zhang","year":"2022","journal-title":"npj Vaccines"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.pt.2016.04.013","article-title":"The Past, Present, and Future of Genetic Manipulation in Toxoplasma gondii","volume":"32","author":"Wang","year":"2016","journal-title":"Trends Parasitol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"8243","DOI":"10.1038\/s41598-023-34863-9","article-title":"A state-of-the-art methodology for high-throughput in silico vaccine discovery against protozoan parasites and exemplified with discovered candidates for Toxoplasma gondii","volume":"13","author":"Goodswen","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1186\/s13071-024-06461-9","article-title":"Live-attenuated Pru\u0394gra72 strain of Toxoplasma gondii induces strong protective immunity against acute and chronic toxoplasmosis in mice","volume":"17","author":"Li","year":"2024","journal-title":"Parasit. Vectors"},{"key":"ref_114","unstructured":"Luo, Y., Zhang, X., Li, Y., Wang, M., Liu, J., Chen, L., Zhang, Z., and Zhu, X.-Q. (2025). Toxoplasma gondii C2 Domain Protein Deletion Mutant as a Promising Vaccine against Toxoplasmosis in Mice. Microb. Biotechnol., e70143."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/415926a","article-title":"De Novo Pyrimidine Biosynthesis Is Required for Virulence of Toxoplasma gondii","volume":"415","author":"Fox","year":"2002","journal-title":"Nature"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"104714","DOI":"10.1016\/j.ijpara.2025.08.002","article-title":"Live-Attenuated Toxoplasma gondii Pru\u0394pp2a-c Mutant Elicits Protective Immunity against Toxoplasmosis in Mice and Cats","volume":"56","author":"Xie","year":"2026","journal-title":"Int. J. Parasitol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nri3598","article-title":"Innate Immunity to Toxoplasma gondii Infection","volume":"14","author":"Yarovinsky","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"El Hajj, H., Lebrun, M., Arold, S.T., Vial, H., Labesse, G., and Dubremetz, J.F. (2007). ROP18 Is a Rhoptry Kinase Controlling the Intracellular Proliferation of Toxoplasma gondii. PLoS Pathog., 3.","DOI":"10.1371\/journal.ppat.0030014"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/s41541-024-00996-9","article-title":"Toxoplasma WH3 \u0394rop18 Acts as a Live Attenuated Vaccine against Acute and Chronic Toxoplasmosis","volume":"9","author":"Wang","year":"2024","journal-title":"npj Vaccines"},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Wu, Y., Zhou, Z., Ying, Z., Xu, Y., Liu, J., and Liu, Q. (2022). Deletion of Toxoplasma Rhoptry Protein 38 (Pru\u0394rop38) as a Vaccine Candidate for Toxoplasmosis in a Murine Model. Biomedicines, 10.","DOI":"10.3390\/biomedicines10061336"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/s41541-022-00518-5","article-title":"Live-attenuated ME49\u0394cdpk3 strain of Toxoplasma gondii protects against acute and chronic toxoplasmosis","volume":"7","author":"Wu","year":"2022","journal-title":"npj Vaccines"},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Melchor, S.J., and Ewald, S.E. (2019). Disease Tolerance in Toxoplasma Infection. Front. Cell. Infect. Microbiol., 9.","DOI":"10.3389\/fcimb.2019.00185"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s40249-023-01109-9","article-title":"A Live Attenuated RH\u0394ompdc\u0394uprt Mutant of Toxoplasma gondii Induces Strong Protective Immunity against Toxoplasmosis in Mice and Cats","volume":"12","author":"Shen","year":"2023","journal-title":"Infect. Dis. Poverty"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.pt.2010.01.009","article-title":"Toxoplasma gondii: Epidemiology, Feline Clinical Aspects, and Prevention","volume":"26","author":"Elmore","year":"2010","journal-title":"Trends Parasitol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"105173","DOI":"10.1016\/j.actatropica.2019.105173","article-title":"An Overview of Leishmanization Experience: A Successful Control Measure and a Tool to Evaluate Candidate Vaccines","volume":"200","author":"Mohebali","year":"2019","journal-title":"Acta Trop."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/348171a0","article-title":"Gene Replacement in Parasitic Protozoa","volume":"348","author":"Cruz","year":"1990","journal-title":"Nature"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1590\/S0074-02761999000400011","article-title":"A Dhfr-Ts-Leishmania major Knockout Mutant Cross-Protects against Leishmania Amazonensis","volume":"94","author":"Veras","year":"1999","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"18218","DOI":"10.1038\/s41598-020-75420-y","article-title":"DDX3 DEAD-Box RNA Helicase (Hel67) Gene Disruption Impairs Infectivity of Leishmania donovani and Induces Protective Immunity against Visceral Leishmaniasis","volume":"10","author":"Pandey","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1111\/mmi.12530","article-title":"Deletion of Vitamin C biosynthesis enzyme, Arabino-1, 4-lactone oxidase in Leishmania donovani results in increased pro-inflammatory responses from host immune cells","volume":"91","author":"Manhas","year":"2014","journal-title":"Mol. Microbiol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"10706","DOI":"10.1038\/srep10706","article-title":"Genetically Engineered Ascorbic Acid-Deficient Live Mutants of Leishmania donovani Induce Long Lasting Protective Immunity against Visceral Leishmaniasis","volume":"5","author":"Anand","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/1756-3305-4-150","article-title":"Leishmania infantum HSP70-II Null Mutant as Candidate Vaccine against Leishmaniasis: A Preliminary Evaluation","volume":"4","author":"Folgueira","year":"2011","journal-title":"Parasit. Vectors"},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"Solana, J.C., Ram\u00edrez, L., Cook, E.C., Hern\u00e1ndez-Garc\u00eda, E., Sacrist\u00e1n, S., Mart\u00edn, M.E., Manuel Gonz\u00e1lez, V., Reguera, R.M., Bala\u00f1a-Fouce, R., and Fresno, M. (2020). Subcutaneous Immunization of Leishmania HSP70-II Null Mutant Line Reduces the Severity of the Experimental Visceral Leishmaniasis in BALB\/c Mice. Vaccines, 8.","DOI":"10.3390\/vaccines8010141"},{"key":"ref_133","doi-asserted-by":"crossref","unstructured":"Solana, J.C., Ram\u00edrez, L., Corvo, L., De Oliveira, C.I., Barral-Netto, M., Requena, J.M., Iborra, S., and Soto, M. (2017). Vaccination with a Leishmania infantum HSP70-II Null Mutant Confers Long-Term Protective Immunity against Leishmania major Infection in Two Mice Models. PLoS Negl. Trop. Dis., 11.","DOI":"10.1371\/journal.pntd.0005644"},{"key":"ref_134","doi-asserted-by":"crossref","unstructured":"Soto, M., Ram\u00edrez, L., Solana, J.C., Cook, E.C.L., Hern\u00e1ndez-Garc\u00eda, E., Requena, J.M., and Iborra, S. (2021). Inoculation of the Leishmania infantum HSP70-II Null Mutant Induces Long-Term Protection against L. amazonensis Infection in BALB\/c Mice. Microorganisms, 9.","DOI":"10.3390\/microorganisms9020363"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1365-2958.2010.07214.x","article-title":"Characterization of a Leishmania Stage-Specific Mitochondrial Membrane Protein That Enhances the Activity of Cytochrome c Oxidase and Its Role in Virulence","volume":"77","author":"Dey","year":"2010","journal-title":"Mol. Microbiol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"43253","DOI":"10.1074\/jbc.M106806200","article-title":"Expression of a Mutant Form of Leishmania donovani Centrin Reduces the Growth of the Parasite","volume":"276","author":"Selvapandiyan","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.4049\/jimmunol.1202801","article-title":"Live Attenuated Leishmania donovani P27 Gene Knockout Parasites Are Nonpathogenic and Elicit Long-Term Protective Immunity in BALB\/c Mice","volume":"190","author":"Dey","year":"2013","journal-title":"J. Immunol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.cellimm.2018.07.002","article-title":"Development of a New Live Attenuated Leishmania major P27 Gene Knockout: Safety and Immunogenicity Evaluation in BALB\/c Mice","volume":"332","author":"Elikaee","year":"2018","journal-title":"Cell. Immunol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1016\/j.vaccine.2019.04.068","article-title":"Leishmania major P27 Gene Knockout as a Novel Live Attenuated Vaccine Candidate: Protective Immunity and Efficacy Evaluation against Cutaneous and Visceral Leishmaniasis in BALB\/c Mice","volume":"37","author":"Elikaee","year":"2019","journal-title":"Vaccine"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.4049\/jimmunol.0900276","article-title":"Intracellular Replication-Deficient Leishmania donovani Induces Long Lasting Protective Immunity against Visceral Leishmaniasis","volume":"183","author":"Selvapandiyan","year":"2009","journal-title":"J. Immunol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/j.vaccine.2013.01.048","article-title":"Induction of Immunogenicity by Live Attenuated Leishmania donovani Centrin Deleted Parasites in Dogs","volume":"31","author":"Fiuza","year":"2013","journal-title":"Vaccine"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.vaccine.2014.11.039","article-title":"Vaccination Using Live Attenuated Leishmania Donovani Centrin Deleted Parasites Induces Protection in Dogs against Leishmania infantum","volume":"33","author":"Fiuza","year":"2015","journal-title":"Vaccine"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"e12423","DOI":"10.1111\/pim.12423","article-title":"American Cutaneous Leishmaniasis: In Situ Immune Response of Patients with Recent and Late Lesions","volume":"39","author":"Gomes","year":"2017","journal-title":"Parasite Immunol."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.actatropica.2018.09.022","article-title":"Gene Expression Profile of Cytokines Produced in Biopsies from Patients with American Cutaneous Leishmaniasis","volume":"189","author":"Gomes","year":"2019","journal-title":"Acta Trop."},{"key":"ref_145","doi-asserted-by":"crossref","unstructured":"Caldas, A., Favali, C., Aquino, D., Vinhas, V., van Weyenbergh, J., Brodskyn, C., Costa, J., Barral-Netto, M., and Barral, A. (2005). Balance of IL-10 and Interferon-\u03b3 Plasma Levels in Human Visceral Leishmaniasis: Implications in the Pathogenesis. BMC Infect. Dis., 5.","DOI":"10.1186\/1471-2334-5-113"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"106153","DOI":"10.1016\/j.actatropica.2021.106153","article-title":"Live Attenuated Leishmania major P27 Gene Knockout as a Novel Vaccine Candidate: A Study on Safety, Protective Immunity and Efficacy against Canine Leishmaniasis Caused by Leishmania infantum","volume":"225","author":"Elikaee","year":"2022","journal-title":"Acta Trop."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"101984","DOI":"10.1016\/j.cimid.2023.101984","article-title":"Live Attenuated Leishmania infantum Centrin Deleted Mutant (LiCen) as a Novel Vaccine Candidate: A Field Study on Safety, Immunogenicity, and Efficacy against Canine Leishmaniasis","volume":"97","author":"Zarei","year":"2023","journal-title":"Comp. Immunol. Microbiol. Infect. Dis."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"e00433-22","DOI":"10.1128\/mbio.00433-22","article-title":"The Leishmania donovani Ortholog of the Glycosylphosphatidylinositol Anchor Biosynthesis Cofactor PBN1 Is Essential for Host Infection","volume":"13","author":"Roberts","year":"2022","journal-title":"mBio"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"14636","DOI":"10.1038\/s41598-024-64592-6","article-title":"Manufacturing and Preclinical Toxicity of GLP Grade Gene Deleted Attenuated Leishmania donovani Parasite Vaccine","volume":"14","author":"Avishek","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_150","doi-asserted-by":"crossref","unstructured":"Perez Brandan, C., Padilla, A.M., Xu, D., Tarleton, R.L., and Basombrio, M.A. (2011). Knockout of the Dhfr-Ts Gene in Trypanosoma cruzi Generates Attenuated Parasites Able to Confer Protection against a Virulent Challenge. PLoS Negl. Trop. Dis., 5.","DOI":"10.1371\/journal.pntd.0001418"},{"key":"ref_151","doi-asserted-by":"crossref","unstructured":"S\u00e1nchez-Vald\u00e9z, F.J., P\u00e9rez Brand\u00e1n, C., Ram\u00edrez, G., Uncos, A.D., Zago, M.P., Cimino, R.O., Cardozo, R.M., Marco, J.D., Ferreira, A., and Basombr\u00edo, M.\u00c1. (2014). A Monoallelic Deletion of the TcCRT Gene Increases the Attenuation of a Cultured Trypanosoma cruzi Strain, Protecting against an In Vivo Virulent Challenge. PLoS Negl. Trop. Dis., 8.","DOI":"10.1371\/journal.pntd.0002696"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1128\/IAI.00400-07","article-title":"Impairment of Infectivity and Immunoprotective Effect of a LYT1 Null Mutant of Trypanosoma cruzi","volume":"76","author":"Zago","year":"2008","journal-title":"Infect. Immun."},{"key":"ref_153","doi-asserted-by":"crossref","unstructured":"Souza-Silva, T.G., Neves, E.G.A., Koh, C., Teixeira-Carvalho, A., Ara\u00fajo, S.S., Nunes, M.D.C.P., Gomes, J.D.A.S., Gollob, K.J., and Dutra, W.O. (2024). Correlation of Blood-Based Immune Molecules with Cardiac Gene Expression Profiles Reveals Insights into Chagas Cardiomyopathy Pathogenesis. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1338582"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.humimm.2008.05.013","article-title":"Analysis of the Cellular Immune Response in Patients with the Digestive and Indeterminate Forms of Chagas\u2019 Disease","volume":"69","author":"Ribeiro","year":"2008","journal-title":"Hum. Immunol."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/s41541-023-00647-5","article-title":"Immunization with a Trypanosoma cruzi Cyclophilin-19 Deletion Mutant Protects against Acute Chagas Disease in Mice","volume":"8","author":"Jha","year":"2023","journal-title":"npj Vaccines"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"8772","DOI":"10.1074\/jbc.M112.421057","article-title":"Secreted Trypanosome Cyclophilin Inactivates Lytic Insect Defense Peptides and Induces Parasite Calcineurin Activation and Infectivity","volume":"288","author":"Kulkarni","year":"2013","journal-title":"J. Biol. Chem."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1126\/science.1112631","article-title":"The Genome Sequence of Trypanosoma cruzi, Etiologic Agent of Chagas Disease","volume":"309","author":"Myler","year":"2005","journal-title":"Science"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.molbiopara.2015.10.004","article-title":"Expanding the Tool Box for Genetic Manipulation of Trypanosoma cruzi","volume":"203","author":"Laibida","year":"2015","journal-title":"Mol. Biochem. Parasitol."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"e03478-21","DOI":"10.1128\/mbio.03478-21","article-title":"Disruption of Active Trans-Sialidase Genes Impairs Egress from Mammalian Host Cells and Generates Highly Attenuated Trypanosoma cruzi parasites","volume":"13","author":"Mugge","year":"2022","journal-title":"mBio"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1111\/j.1462-5822.2012.01831.x","article-title":"Trypanosoma cruzi Trans-Sialidase as a Multifunctional Enzyme in Chagas\u2019 Disease","volume":"14","author":"Schenkman","year":"2012","journal-title":"Cell. Microbiol."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"13388","DOI":"10.1074\/jbc.M109.096305","article-title":"Trypanosoma cruzi Subverts Host Cell Sialylation and May Compromise Antigen-Specific CD8+ T Cell Responses","volume":"285","author":"Carvalho","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_162","doi-asserted-by":"crossref","unstructured":"Greif, G., Chiribao, M.L., D\u00edaz-Viraqu\u00e9, F., Sanz-Rodr\u00edguez, C.E., and Robello, C. (2026). The complete genome of Trypanosoma cruzi reveals 32 chromosomes and three genomic compartments. BMC Genom., 27.","DOI":"10.1186\/s12864-025-12482-0"},{"key":"ref_163","unstructured":"World Health Organization (2026, April 30). R&D Funding Flows for Neglected Diseases, by Disease, Year and Funding Category. Available online: https:\/\/www.who.int\/observatories\/global-observatory-on-health-research-and-development\/monitoring\/r-d-funding-flows-for-neglected-diseases-by-disease-year-and-funding-category."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","article-title":"Lipid nanoparticles for mRNA delivery","volume":"6","author":"Hou","year":"2021","journal-title":"Nat. Rev. Mater."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.omtn.2019.01.013","article-title":"Optimization of Lipid Nanoparticles for Intramuscular Administration of mRNA Vaccines","volume":"15","author":"Hassett","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_166","doi-asserted-by":"crossref","unstructured":"Gote, V., Bolla, P.K., Kommineni, N., Butreddy, A., Nukala, P.K., Palakurthi, S.S., and Khan, W. (2023). A Comprehensive Review of mRNA Vaccines. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24032700"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"122331","DOI":"10.1016\/j.lfs.2023.122331","article-title":"Vaccine Development: Current Trends and Technologies","volume":"336","author":"Poria","year":"2024","journal-title":"Life Sci."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/s41573-021-00283-5","article-title":"mRNA Vaccines for Infectious Diseases: Principles, Delivery and Clinical Translation","volume":"20","author":"Chaudhary","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1056\/NEJMoa2307079","article-title":"Efficacy and Safety of an mRNA-Based RSV PreF Vaccine in Older Adults","volume":"389","author":"Wilson","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.chom.2018.06.008","article-title":"Malaria Vaccines: Recent Advances and New Horizons","volume":"24","author":"Draper","year":"2018","journal-title":"Cell Host Microbe"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/s41541-021-00345-0","article-title":"Messenger RNA expressing PfCSP induces functional, protective immune responses against malaria in mice","volume":"6","author":"Mallory","year":"2021","journal-title":"npj Vaccines"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s41541-025-01089-x","article-title":"iDC-targeting PfCSP mRNA vaccine confers superior protection against Plasmodium compared to conventional mRNA","volume":"10","author":"Yanik","year":"2025","journal-title":"npj Vaccines"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41541-022-00577-8","article-title":"mRNA-LNP Expressing PfCSP and Pfs25 Vaccine Candidates Targeting Infection and Transmission of Plasmodium falciparum","volume":"7","author":"Hayashi","year":"2022","journal-title":"npj Vaccines"},{"key":"ref_174","doi-asserted-by":"crossref","unstructured":"Nakamae, S., Miyagawa, S., Ogawa, K., Kamiya, M., Taniguchi, M., Ono, A., Kawaguchi, M., Teklemichael, A.A., Jian, J.Y., and Araki, T. (2023). Induction of liver-resident memory T cells and protection at liver-stage malaria by mRNA-containing lipid nanoparticles. Front Immunol., 14.","DOI":"10.3389\/fimmu.2023.1116299"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"102645","DOI":"10.1016\/j.omtn.2025.102645","article-title":"mRNA-LNP Vaccine Encoding the Plasmodium vivax Circumsporozoite Protein Is Highly Immunogenic and Confers Protection in Mice","volume":"36","author":"Limsalakpetch","year":"2025","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1080\/14760584.2021.1878028","article-title":"Transmission-Blocking Vaccines: Harnessing Herd Immunity for Malaria Elimination","volume":"20","author":"Duffy","year":"2021","journal-title":"Expert Rev. Vaccines"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/s41541-023-00786-9","article-title":"A Pvs25 mRNA Vaccine Induces Complete and Durable Transmission-Blocking Immunity to Plasmodium vivax","volume":"8","author":"Kunkeaw","year":"2023","journal-title":"npj Vaccines"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s41586-020-2220-1","article-title":"Anti-PfGARP Activates Programmed Cell Death of Parasites and Reduces Severe Malaria","volume":"582","author":"Raj","year":"2020","journal-title":"Nature"},{"key":"ref_179","doi-asserted-by":"crossref","unstructured":"Waghela, I.N., Mallory, K.L., Taylor, J.A., Schneider, C.G., Savransky, T., Janse, C.J., Lin, P.J.C., Tam, Y.K., Weissman, D., and Angov, E. (2022). Exploring in vitro expression and immune potency in mice using mRNA encoding the Plasmodium falciparum malaria antigen, CelTOS. Front Immunol., 13.","DOI":"10.3389\/fimmu.2022.1026052"},{"key":"ref_180","doi-asserted-by":"crossref","unstructured":"Ott, A.C., Loll, P.J., James, M., and Burns, J. (2025). An mRNA Vaccine Expressing Blood-Stage Malaria Antigens Induces Complete Protection Against Lethal Plasmodium yoelii. Vaccines, 13.","DOI":"10.3390\/vaccines13070702"},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1038\/s41467-018-05041-7","article-title":"Neutralization of the Plasmodium-encoded MIF ortholog confers protective immunity against malaria infection","volume":"9","author":"Garcia","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1038\/s41590-023-01562-6","article-title":"mRNA vaccine against malaria tailored for liver-resident memory T cells","volume":"24","author":"Ganley","year":"2023","journal-title":"Nat. Immunol."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/j.vaccine.2005.09.053","article-title":"Induction of Protective Immunity against Toxoplasmosis in Mice by Immunization with Toxoplasma Gondii RNA","volume":"24","author":"Aline","year":"2006","journal-title":"Vaccine"},{"key":"ref_184","doi-asserted-by":"crossref","unstructured":"Luo, F., Zheng, L., Hu, Y., Liu, S., Wang, Y., Xiong, Z., Hu, X., and Tan, F. (2017). Induction of protective immunity against Toxoplasma gondii in mice by nucleoside triphosphate hydrolase-II (NTPase-II) self-amplifying RNA vaccine encapsulated in lipid nanoparticle (LNP). Front. Microbiol., 8.","DOI":"10.3389\/fmicb.2017.00605"},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"E4133","DOI":"10.1073\/pnas.1600299113","article-title":"Dendrimer-RNA Nanoparticles Generate Protective Immunity against Lethal Ebola, H1N1 Influenza, and Toxoplasma gondii Challenges with a Single Dose","volume":"113","author":"Chahal","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s40249-025-01332-6","article-title":"A Novel Combined Quadrivalent Self-Amplifying mRNA-LNP Vaccine Provokes Protective Immunity against Acute and Chronic Toxoplasmosis in Mice","volume":"14","author":"Wu","year":"2025","journal-title":"Infect. Dis. Poverty"},{"key":"ref_187","doi-asserted-by":"crossref","unstructured":"Zhang, Y., Li, D., Shen, Y., Li, S., Lu, S., and Zheng, B. (2023). Immunization with a Novel mRNA Vaccine, TGGT1_216200 mRNA-LNP, Prolongs Survival Time in BALB\/c Mice against Acute Toxoplasmosis. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1161507"},{"key":"ref_188","doi-asserted-by":"crossref","unstructured":"Li, D., Zhang, Y., Li, S., and Zheng, B. (2023). A Novel Toxoplasma Gondii TGGT1_316290 mRNA-LNP Vaccine Elicits Protective Immune Response against Toxoplasmosis in Mice. Front. Microbiol., 14.","DOI":"10.3389\/fmicb.2023.1145114"},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"e0286623","DOI":"10.1128\/spectrum.02866-23","article-title":"A Novel mRNA Vaccine, TGGT1_278620 mRNA-LNP, Prolongs the Survival Time in BALB\/c Mice with Acute Toxoplasmosis","volume":"12","author":"Zhang","year":"2024","journal-title":"Microbiol. Spectr."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/s12951-025-03201-8","article-title":"The immunogenic potential of an optimized mRNA lipid nanoparticle formulation carrying sequences from virus and protozoan antigens","volume":"23","author":"Fernandes","year":"2025","journal-title":"J. Nanobiotechnol."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/s41541-025-01213-x","article-title":"IL-12 mRNA-LNP promotes dermal resident memory CD4+ T cell development","volume":"10","author":"Alameh","year":"2025","journal-title":"npj Vaccines"},{"key":"ref_192","doi-asserted-by":"crossref","unstructured":"Duthie, M.S., Van Hoeven, N., MacMillen, Z., Picone, A., Mohamath, R., Erasmus, J., Hsu, F.-C., Stinchcomb, D.T., and Reed, S.G. (2018). Heterologous Immunization with Defined RNA and Subunit Vaccines Enhances T Cell Responses That Protect Against Leishmania donovani. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.02420"},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"100066","DOI":"10.1016\/j.crimmu.2023.100066","article-title":"Heterologous mRNA-Protein Vaccination with Tc24 Induces a Robust Cellular Immune Response against Trypanosoma cruzi, Characterized by an Increased Level of Polyfunctional CD8+ T-Cells","volume":"4","author":"Poveda","year":"2023","journal-title":"Curr. Res. Immunol."},{"key":"ref_194","doi-asserted-by":"crossref","unstructured":"Versteeg, L., Adhikari, R., Robinson, G., Lee, J., Wei, J., Islam, N., Keegan, B., Russell, W.K., Poveda, C., and Villar, M.J. (2024). Immunopeptidomic MHC-I Profiling and Immunogenicity Testing Identifies Tcj2 as a New Chagas Disease mRNA Vaccine Candidate. PLoS Pathog., 20.","DOI":"10.1371\/journal.ppat.1012764"},{"key":"ref_195","unstructured":"World Health Organization (2022). WHO Expert Committee on Biological Standardization: Seventy-Fifth Report, World Health Organization. Available online: https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/d4fbe58a-ef0c-4bc2-812b-ab4952e89f13\/content."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/inthealth\/ihab010","article-title":"Disrupting vaccine logistics","volume":"13","author":"James","year":"2021","journal-title":"Int. Health"},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"e013073","DOI":"10.1136\/bmjgh-2023-013073","article-title":"COVID-19 vaccination implementation in 52 African countries: Trajectory and implications for future pandemic preparedness","volume":"8","author":"Wariri","year":"2023","journal-title":"BMJ Glob. Health"},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1080\/14760584.2021.1971522","article-title":"To mix or not to mix? A rapid systematic review of heterologous prime-boost COVID-19 vaccination","volume":"20","author":"Chiu","year":"2021","journal-title":"Expert Rev. Vaccines"},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.vaccine.2021.12.026","article-title":"Did the European suspension of the AstraZeneca vaccine decrease vaccine acceptance during the COVID-19 pandemic?","volume":"40","author":"Petersen","year":"2022","journal-title":"Vaccine"},{"key":"ref_200","doi-asserted-by":"crossref","unstructured":"Bundi, C.K., Mu\u00f1oz, O., Kibwana, E., Bellamy, D., Stockdale, L., Barrett, J.R., McHugh, K., Mtaka, I., Kalinga, W., and Kimani, D. (2026). B and T cell responses to pre-erythrocytic R21\/Matrix-M and blood-stage RH5.1\/Matrix-M malaria vaccines in endemic settings. Front. Immunol., 17.","DOI":"10.3389\/fimmu.2026.1743327"},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S1473-3099(24)00752-7","article-title":"Safety and efficacy of the blood-stage malaria vaccine RH5.1\/Matrix-M in Burkina Faso: Interim results of a double-blind, randomised, controlled, phase 2b trial in children","volume":"25","author":"Natama","year":"2025","journal-title":"Lancet Infect. Dis."}],"container-title":["Microorganisms"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-2607\/14\/5\/1112\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T04:14:56Z","timestamp":1778904896000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-2607\/14\/5\/1112"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,14]]},"references-count":201,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["microorganisms14051112"],"URL":"https:\/\/doi.org\/10.3390\/microorganisms14051112","relation":{},"ISSN":["2076-2607"],"issn-type":[{"value":"2076-2607","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,14]]}}}